... efficacy rate in preventing death and serious condition during its third phase of trials, the vaccine developer, the Center for Genetic Engineering and ...
https://www.google.com/url?rct=j&sa=t&url=https://www.urdupoint.com/en/health/cubas-homegrown-vaccine-abdala-shows-100-ef-1305030.html&ct=ga&cd=CAIyGjg0YzkwMzEwZTQwYzQxNjA6Y29tOmVuOlVT&usg=AFQjCNHTE0yRYcufHk3TMDxdDxe2xWwh6A
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.